home / stock / phio / phio news

PHIO News and Press, Phio Pharmaceuticals Corp. From 11/10/20

Stock Information
Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com
Menu
PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...
PHIO - Beyond Meat, Penumbra leads premarket losers' pack

Beyond Meat (BYND) -23% on Q3 earnings release.InnSuites Hospitality (IHT) -20%.Jumia Technologies (JMIA) -19% on Q3 earnings release.Aurora Cannabis (ACB) -13%.Applied UV (AUVI) -13%.GasLog Partners (GLOP) -13% on Q3 earnings release.Waitr Holdings (WTRH) -...
PHIO - Phio soars 22% on positive in vivo data on combination PD-1 and TIGIT therapy in cancer

Phio Pharmaceuticals (PHIO) jumps 22% premarket after in reaction to positive data from an in vivo study that shows the strong antitumoral efficacy of individual INTASYL pipeline products, including PH-762, PH-790 and PH-804.These data were presented during The Society for Immu...

PHIO - Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment

Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment The new data was presented at the SITC 2020 Virtual Scientific Program PR Newswire MARLBOROUGH, Mass., Nov. 9, 2020 ...

PHIO - Phio Pharmaceuticals Announces Three Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Phio Pharmaceuticals Announces Three Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting PR Newswire MARLBOROUGH, Mass., Oct. 26, 2020 MARLBOROUGH, Mass. , Oct. 26, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (N...
PHIO - Phio Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

MARLBOROUGH, Mass. , Sept. 9, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced ...

PHIO - Phio Pharmaceuticals EPS beats by $0.31

Phio Pharmaceuticals (NASDAQ: PHIO ) : Q2 GAAP EPS of -$0.34 beats by $0.31 . More news on: Phio Pharmaceuticals Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...

PHIO - Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

MARLBOROUGH, Mass. , Aug. 12, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its fin...
PHIO - CNTG, NAK among premarket losers

Hexindai (NASDAQ: HX ) -14% . More news on: Hexindai Inc., Phio Pharmaceuticals Corp., Centogene N.V., Stocks on the move, , Read more ...

PHIO - U.S. debut on horizon for iTeos Therapeutics

ITeos Therapeutics ( ITOS ) has filed a preliminary prospectus for a $100M IPO. More news on: Roche Holding AG, Phio Pharmaceuticals Corp., Agenus Inc., Healthcare stocks news, IPO News, , Read more ...

PHIO - Phio Presents Additional Data Supporting Potential of TIGIT Targeting INTASYL Compound in the Tumor Microenvironment at AACR 2020

MARLBOROUGH, Mass. , June 22, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced a post...
Previous 10 Next 10